• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Public Health . Analysis of influenza A, influenza B and Mycoplasma pneumoniae infection in children hospitalized with acute respiratory tract

tetano

Editor, Senior Moderator
Front Public Health


. 2026 Mar 6:14:1762939.
doi: 10.3389/fpubh.2026.1762939. eCollection 2026.
Analysis of influenza A, influenza B and Mycoplasma pneumoniae infection in children hospitalized with acute respiratory tract infection in Xi'an from 2021 to 2023

Haijin Zhang[SUP] 1 2 [/SUP], Guihua Zhuang[SUP] 2 [/SUP], Bingtong Zhao[SUP] 2 [/SUP], Zengguo Wang[SUP] 3 [/SUP]


Affiliations
Abstract

Objective: To evaluate the occurrence of three pathogens, influenza virus A (FluA), influenza virus B (FluB) and Mycoplasma pneumoniae (Mp) in children hospitalized with acute respiratory tract infection (ARTI) between 2021 and 2023.
Methods: FluA, FluB and Mp were detected by antigen/antibody kit in specimens from 29,014 children with ARTI admitted to Xi'an Children's Hospital.
Results: The total pathogen detection rate was 43.79% (12,707/29014) with 30.14% (8,745/29014) Mp-positive cases, 7.08% (55/29014) FluA-positive and 6.57% (1907/29014) FluB-positive. Total detection rates were 28.05% (2,472/8813) in 2021, 29.38% (2,550/8680) in 2022 and 66.70% (7,685/11521) in 2023. Co-infection rates with two or more pathogens increased over the period of interest from 0.75% (66/8813) in 2021, 0.93% (81/8680) in 2022 to 2.38% (274/11521) in 2023 (χ [SUP]2[/SUP] = 115.931, p < 0.001). FluA detection also increased and was present in 0.53% cases in 2021, 6.01% in 2022 and 12.90% in 2023, reaching a peak in February 2023 of 17.83% and March 2023 of 64.42%. FluB detection rates were more stable at 5.25% in 2021, 7.67% in 2022 and 6.75% in 2023, reaching a peak of 22.17% in December 2023. Mp detection was higher in 2023 at 47.05% with a peak of 82.21% in October 2023 than in 2021 (15.89%) or 2022 (15.69%). More FluA-positive cases were seen in the >12 age groups than in younger children and FluB detection also increased with age. Mp infection was detected in the >4 age group.
Conclusion: The pathogen spectrum and epidemiology of ARTI changed between 2021 and 2023. Age-specific bandings of infection were seen in the cohort of children. Outbreaks of FluA, FluB and Mp influence the pathology of ARTI.

Keywords: Mycoplasma pneumoniae; Xi’an; acute respiratory tract infection; influenza A/B; pediatric respiratory infection.

 
Back
Top Bottom